NCT03252912View on ClinicalTrials.gov

Study in Leptomeningeal Metastases of Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

February 3, 2020

Study Completion Date

September 15, 2020

Conditions
Breast Cancer
Interventions
BIOLOGICAL

blood samples

Two EDTA tubes (5 mL) and two dried tubes (5mL) will be will be taken the same day as the first lumbar .

Trial Locations (1)

34298

Institut régional du Cancer de Montpellier, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT03252912 - Study in Leptomeningeal Metastases of Breast Cancer | Biotech Hunter | Biotech Hunter